VCCircle Healthcare Investment Summit 2010
Indian healthcare is perhaps on the threshold of a golden age with rising income levels, penetration of insurance, increased life expectancy and lifestyle diseases, greater awareness and, more importantly, higher wallet spends on well-being are the macro trends making this sector red-hot in terms of attractiveness.
While rural and primary healthcare is still largely in the public domain, private sector healthcare delivery is clearly leading trends in urban India and is now gradually spreading its wings to tier II and tier III cities and towns. From the basic pill you pop to the blood sugar test to diagnostics chains, daycare surgery centres, specialty maternity clinics, air ambulance services, generic implantable stent-makers, the spread is vast and throws up interesting niches in this multi-layered theme.
The sheer market size coupled with its non-cyclical and recession-proof nature make this sector a winner. Sample this data: India’s healthcare sector is expected to grow at 23% annually to become a $77-billion industry by 2012 with diagnostics contributing $2.5 billion, a Yes Bank-Assocham report says. Alongside this staggering growth is a rather worrying statistic on the demand-supply mismatch in basic healthcare in India. At present, there are only nine beds per 10,000 people in India as opposed to the world average of 40 beds per 10,000. That is the kind of opportunity set for healthcare play in India.
VCCircle’s second edition of healthcare investment summit will peel the various layers of this compelling vertical story, try to discover new sub-plots and also create a common language for medico-entrepreneurs and investors.
Some of the issues the summit will touch upon: Where is consolidation in generic pharma play headed? What is the right healthcare delivery model for India-Hospitals like Apollo or Fortis, specialized chains like HCG or a combination of both? What are the challenges to scaling diagnostic delivery chains? What are the new opportunities in medical devices space? Will genericisation in devices such as implantables (stents etc) mirror generic drug industry in terms of scaling and deal trends? Are investors prepared for long gestation play in healthcare particularly mainline hospitals? Are doctors willing to handle power point presentations along with their steths? Is real estate one of the biggest challenges to scale in healthcare delivery? Are Indian hospitals chasing the Asian story?
Be sure to hear what healthcare CEOs and medico-entrepreneurs have to say as they take a day off from surgical scalpels to make their point on the business of health. The investment summit--which will see participation from top line healthcare industry investors, investment bankers, doctors and medico-entrepreneurs, healthcare CEOs and thought leaders--will undoubtedly be an unmissable opportunity for both participants and attendees as constructive deliberations may bring to light some current and futuristic trends that can define the course of the industry.
8:00 am to 9:00 am
Tea & Registration
9:00am - 9:15am
Introduction Note
Sahad P.V., Founder & Publisher, VCCircle Network
9:20am- 10:30am
Panel I: Understanding The Hospital Anatomy
- Is Big Beautiful or small, regional and discipline focused plays more attractive?
- Daycare surgeries and hub-and-spoke model. What are the opportunities set in this space?
- M&A and consolidation: Large branded hospitals are busy scanning the market for smaller-sized hospitals to consolidate their bed strength. Are more Fortis-Wockhardt/Fortis-Malar Hospitals kind of deals in the offing?
- The big Asian market: Either organically or through M&As, Indian healthcare seems to be eyeing opportunities in the sub-continent, Asian, Middle-East region. Is it the diaspora advantage? How large is this play?
- Real estate business models. How to go asset-light?
Hari Buggana - MD, Evolvence India Life Sciences Fund (Moderator)
Rajen Padukone, CEO, Manipal Health Systems
Sandeep Naik - Co-Head, Apax Partners India
Siddharth Dhondiyal - Vice President, India Value Fund Advisors
Leo Puri - MD, Warburg Pincus India
Vishal Bali - CEO, Fortis Hospitals
10:30am- 10:45am
Diagnostics Play: Potential, Regulatory Environment & Scale Challenges
G S K Velu - Vice Chairman, Metropolis Health Services Ltd.
10:45am- 11:10am
Tea & Networking Break
11:10am- 11:40am
New and innovative business models in healthcare delivery
Alistair Stranack - Partner, The Parthenon Group
11:40am- 12:50pm
Panel II: Diagnostics, Devices, Products: The Litmus Test
--With just a handful of large chains, diagnostics is still a much fragmented play. What is holding this sector back?
--Medical devices and products: What is the opportunity set in the medical devices play? Is there scope for genericisation in this space? What is the investor interest?
--Surgical products, implantables, blood products and stem cell products: What are the opportunities?
Avnish Bajaj - MD, Matrix Partners India (Moderator)
Dr. Ajay Aggarwal - Director, Diwan Chand Medical Services Pvt. Ltd.
Mayur Abhaya Srisrimal - President, LifeCell International
B N Manohar - CEO, Stempeutics Research Pvt Ltd
Shiraz Bugwadia - Director, o3 Capital
12:50pm- 2:00 pm
Lunch & Networking
2:00pm- 3:10pm
Panel III: Healthcare Enablers
- Insurance penetration: How it will give a push to healthcare
- Affordable healthcare, telemedicine:How to democratize healthcare?
- Alternative therapy and pharma retail
- Cost arbitrage: With healthcare facilities in India at just one-third to even one-eighth its cost in western nations, what can be done to cash in on this opportunity
Ratan Jalan - CEO, Medium Healthcare (Moderator)
Prashanth Prakash - Partner, Accel India
Sanjay Singh - Founder, Swas Healthcare Pvt. Ltd.
DA Prasanna, - CMD, Ecron Acunova
Rajesh Singhal - Managing Partner, Milestone Religare Investment Advisors Pvt Ltd.
Vikram Gupta - COO, IndiaVenture Advisors
Sanjay Arte - Partner, India Value Fund Advisors
3:10 pm - 4:20 pm
Tea & Networking
3:10pm- 4:20pm
VCCircle Lounge
VCCircle Lounge is a new initiative from VCCircle where companies and investors can meet and network in a structured manner in a separate enclosure. Here companies can make their elevator pitch to a group of select private equity investors and venture capitalists, while investors can sell their funds to India's fastest growing enterprises.
4:20pm- 5:30pm
Panel IV: VCCircle Faceoff: The Lingua Franca Of Medico-Entrepreneurs & Investors
- Do investors have the patience for a long-gestation play as hospitals typically need at least five years to start making money?
- Are investors willing to go beyond the month-on-month profitability approach and understand the social implications of running a healthcare business? Hospitals cannot turn away emergencies and may have to cross-subsidise poorer patients.
- Are investors able to add value in terms of mobilizing policy advocacy in this sector?
- Are doctors willing to don a CEO’s hat or are open to separate the role of medical head and business head?
A.K. Purwar - Chairman, IndiaVenture Advisors (Moderator)
K. Ravindranath - MD, Global Hospitals Ltd.
B.Bhaskar Rao - MD, Krishna Institute of Medical Sciences Ltd.
Rajiv Sharma - CEO, Sterling Hospitals
Darius Pandole - Partner, New Silk Route Advisors
Dr Dharminder Nagar, MD, Paras Hospital
5:30pm- 5:40pm
Concluding Remarks
6pm onwards
VCCircle Unwind
VCCircle introduces Unwind, an informal networking zone over cocktails
India Value Fund Advisors (IVFA) was established in 1999 with a focus on investing in and transforming mid-sized profitable businesses into world-class industry leaders, built on the strong foundation of IVFA Values. Steered since its inception by Vishal Nevatia, IVFA has built deep knowledge and skills in the Indian markets and has successfully launched five separate investment funds with a combined corpus of over US$ 1.8 billion. Currently, IVFA is investing out of IVF - V, which has a corpus of US$ 682 million.
IVFA follows either ‘Buy and Build' or ‘Invest and Build' business model. In ‘Buy and Build’, IVFA acquires majority equity stakes, partners with high quality management teams and entrepreneurs to build scale and profitability. On the other hand, in ‘Invest and Build', IVFA acquires significant minority equity stakes and plays a supportive role to existing entrepreneurs in transforming businesses. Over 70% of all capital invested by IVFA till date is under Buy and Build model.
IVFA’s insights and understanding of India has been sharpened over the last 16 years by investing over US$ 1 billion in more than 40 Indian businesses. It has successfully guided these companies in making the transition into well established and large businesses that are valuable, enduring, socially responsible and are creating immense wealth for all stakeholders. Although sector agnostic, IVFA has built strong understanding of sectors like Media & Entertainment, Healthcare, Logistics, Supply Chain & Retailing, Infrastructure Services, Education and Clean Energy.
The IVFA team has been structured with a balanced mix of 9 Investment and 16 Business Managers, who bring with them several hundred man-years of industry experience to achieve the above objective.
IVFA truly values its relationships with investors, entrepreneurs and management teams. It is also very conscious of its fiduciary duty towards the capital under management. This capital has been contributed by over 35 high quality international institutions with a combined investible capital base of over US$ 1 trillion. For more information on IVFA, we request you to please visit http://www.ivfa.com.
o3 Capital is a mid-market investment bank, providing financial and strategic advice to clients. The company is built on two core businesses – Corporate Finance and Alternate Asset Management.
o3 Capital serves a wide range of clients including cutting-edge start-ups, established market leaders, private equity houses and large global corporate entities, across select verticals - Consumer, Healthcare, Industrials, Financial services, Technology and Digital. o3 Capital has successfully consummated 110+transactions in the last 9 years aggregating to over USD 4.5 bn in transaction value.
Evolvence India Life Sciences Fund is a Mauritius-based Private Equity fund established to provide growth capital to companies operating in the Indian healthcare sector.
EILSF invests in small to mid-sized pharmaceutical, biopharmaceutical, medical device, contract R&D, and healthcare services companies which are either located in India or which derive significant competitive advantage from operations located in India. Examples of investments include providing capital for capacity expansion, development of generic versions of drugs facing patent expiry, domestic and international acquisitions, and for up-grading existing infrastructure to emerge as 'partner of choice' for contract R&D and manufacturing activities.
Evolvence India Life Sciences Fund is a Mauritius-based Private Equity fund established to provide growth capital to companies operating in the Indian healthcare sector.
EILSF invests in small to mid-sized pharmaceutical, biopharmaceutical, medical device, contract R&D, and healthcare services companies which are either located in India or which derive significant competitive advantage from operations located in India. Examples of investments include providing capital for capacity expansion, development of generic versions of drugs facing patent expiry, domestic and international acquisitions, and for up-grading existing infrastructure to emerge as 'partner of choice' for contract R&D and manufacturing activities.
The Parthenon Group is a leading advisory firm focused on strategy consulting with offices in Boston, London, Mumbai, and San Francisco. Since its inception in 1991, the firm has embraced a unique approach to strategic advisory services built on long-term client relationships, a willingness to share risk, an entrepreneurial spirit, and customized insights. This unique approach has established the firm as the strategic advisor of choice for CEOs and business leaders of Global 1000 corporations, high-potential growth companies, private equity firms, educational institutions, and healthcare organizations.
As a leading advisor to the healthcare industry, our Global Healthcare Practice offers unparallel services to clients across many markets, including investors in healthcare, governments, hospitals/outpatient clinics, insurers, pharmaceutical and medical device companies.
The Parthenon Group is a leading advisory firm focused on strategy consulting with offices in Boston, London, Mumbai, and San Francisco. Since its inception in 1991, the firm has embraced a unique approach to strategic advisory services built on long-term client relationships, a willingness to share risk, an entrepreneurial spirit, and customized insights. This unique approach has established the firm as the strategic advisor of choice for CEOs and business leaders of Global 1000 corporations, high-potential growth companies, private equity firms, educational institutions, and healthcare organizations.
As a leading advisor to the healthcare industry, our Global Healthcare Practice offers unparallel services to clients across many markets, including investors in healthcare, governments, hospitals/outpatient clinics, insurers, pharmaceutical and medical device companies.
VCC Events opens up the avenues for participation. Join hands to be a part of India’s largest gathering of alternative investments leaders, industry stakeholders and Asia’s influential limited partners, general partners and marquee advisors. Your chance to actively participate and augment yourself as thought leaders.
ITC Grand Central, Mumbai
ITC Grand Central, Mumbai
Contact: Business Attire
Distance: Dr Babasaheb Ambedkar Road, Parel, Mumbai
Drop us a line and we will call you.
